| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/2014 | US8828985 Carbamate and urea inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/09/2014 | US8828984 Gold(III) complexes containing N-heterocyclic carbene ligand, synthesis, and their applications in cancer treatment and thiol detection |
| 09/09/2014 | US8828983 Macrocycles as factor XIa inhibitors |
| 09/09/2014 | US8828982 Pyrimidine derivatives for the prevention of HIV infection |
| 09/09/2014 | US8828981 Progesterone for the treatment or prevention of spontaneous preterm birth |
| 09/09/2014 | US8828980 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 09/09/2014 | US8828978 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 09/09/2014 | US8828977 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor |
| 09/09/2014 | US8828976 Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection |
| 09/09/2014 | US8828975 Phosphate-containing nanoparticle delivery vehicle |
| 09/09/2014 | US8828974 Substituted propane phosphinic acid derivatives |
| 09/09/2014 | US8828973 Compounds as receptor modulators with therapeutic utility |
| 09/09/2014 | US8828972 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 09/09/2014 | US8828971 Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders |
| 09/09/2014 | US8828969 Pharmaceutical composition for relieving pain |
| 09/09/2014 | US8828968 Nanoparticle of glucidamin for treating tumor and preparation method thereof |
| 09/09/2014 | US8828967 Low molecular weight complexes between iron and maltobionic acid, use thereof for intramuscular or subcutaneous administration in the treatment of anemic states, and new pharmaceutical compositions adapted for these uses |
| 09/09/2014 | US8828966 Method for treatment of macular degeneration by modulating P2Y12 or P2X7 receptors |
| 09/09/2014 | US8828962 SiRNA compositions and methods for potently inhibiting viral infection |
| 09/09/2014 | US8828961 Methods and compositions to protect aquatic invertebrates from disease |
| 09/09/2014 | US8828960 Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828956 Carbohydrate conjugates as delivery agents for oligonucleotides |
| 09/09/2014 | US8828955 Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed |
| 09/09/2014 | US8828954 Use for scopolin and derivatives thereof |
| 09/09/2014 | US8828953 Chemosensory receptor ligand-based therapies |
| 09/09/2014 | US8828952 Sulfated oligosaccharide derivatives |
| 09/09/2014 | US8828951 Glycoside derivatives and uses thereof |
| 09/09/2014 | US8828946 Composition comprising interleukin-1 receptor antagonist and corticosteroid |
| 09/09/2014 | US8828943 Anticonvulsant combination therapy |
| 09/09/2014 | US8828935 Agent for suppressing elevation of blood triglyceride concentration |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828925 Etoposide and doxorubicin conjugates for drug delivery |
| 09/09/2014 | US8828924 Methods of treating a diabetic embryopathy |
| 09/09/2014 | US8828464 Whitened exine shells |
| 09/09/2014 | US8828452 Method for pain control |
| 09/09/2014 | US8828451 Akt sensitization of cancer cells |
| 09/09/2014 | US8828450 Compositions for use against one or more pathogens |
| 09/09/2014 | US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor |
| 09/09/2014 | US8828444 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 09/09/2014 | US8828443 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 09/09/2014 | US8828442 Pharmaceutical solid dispersions |
| 09/09/2014 | US8828440 Corticosteroids for the treatment of joint pain |
| 09/09/2014 | US8828438 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase |
| 09/09/2014 | US8828430 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 09/09/2014 | US8828429 Release-control composition |
| 09/09/2014 | US8828428 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 09/09/2014 | US8828427 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 09/09/2014 | US8828426 Multiparticulate L-carnitine compositions and related methods |
| 09/09/2014 | US8828425 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers |
| 09/09/2014 | US8828392 Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent |
| 09/09/2014 | US8828378 Targeted vectors for cancer immunotherapy |
| 09/09/2014 | US8828373 Polyalkylene glycol derivative and modified bio-related substance |
| 09/09/2014 | US8828366 Hydrating cream foundation in emulsion form |
| 09/09/2014 | US8828361 Tobacco alkaloid releasing chewing gum |
| 09/09/2014 | US8828359 Particulate materials |
| 09/09/2014 | US8828358 In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide |
| 09/09/2014 | US8828317 Antiseptic compositions, methods and systems |
| 09/09/2014 | US8828232 Citrate-based dialysate chemical formulations |
| 09/09/2014 | US8827946 Intranasal granisetron and nasal applicator |
| 09/09/2014 | US8826904 Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
| 09/09/2014 | CA2802130C Cyanoquinoline derivatives |
| 09/09/2014 | CA2789415C Macrolides |
| 09/09/2014 | CA2789236C Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 09/09/2014 | CA2782927C Derivatives of novel peroxides, method of preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne |
| 09/09/2014 | CA2781766C Method of stabilizing reduced coenzyme q10 |
| 09/09/2014 | CA2774040C 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof |
| 09/09/2014 | CA2770087C Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 1oa inhibitors |
| 09/09/2014 | CA2679010C Pellets comprising an active substance matrix resistant to gastric juice |
| 09/09/2014 | CA2667667C Solid or aqueous alkaline preparation comprising a creatine component, process for the production thereof and the use thereof |
| 09/09/2014 | CA2666582C Acetaminophen / ibuprofen combinations |
| 09/09/2014 | CA2657718C Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing |
| 09/09/2014 | CA2656312C Zilpaterol enantiomer compositions and methods of making and using such compositions |
| 09/09/2014 | CA2655933C Polynucleotides and polypeptide sequences involved in cancer |
| 09/09/2014 | CA2655750C 2-arylindole derivatives as mpges-1 inhibitors |
| 09/09/2014 | CA2655317C Ruminant feed supplement containing rice bran to avoid milk fever |
| 09/09/2014 | CA2652840C 2-piperazino-6-chloro-pteridines as pde4-inhibitors for the treatment of inflammatory diseases |
| 09/09/2014 | CA2651659C Lysine related derivatives as hiv aspartyl protease inhibitors |
| 09/09/2014 | CA2645350C Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers |
| 09/09/2014 | CA2641880C Treatment of duchenne muscular dystrophy |
| 09/09/2014 | CA2636700C Methods and compositions for treating feline hyperthyroidism |
| 09/09/2014 | CA2617282C Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 09/09/2014 | CA2616592C Zalcitabine (ddc) boosted lamivudine (3tc) compositions for antiretroviral therapy |
| 09/09/2014 | CA2615577C Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 09/09/2014 | CA2614698C Use of mglur5 (esp. afq056) in gi (esp. gerd) |
| 09/09/2014 | CA2604383C Nutrition with lipids and non-digestible saccharides |
| 09/09/2014 | CA2597596C Liquid formulations of rapamycin for intraocular delivery |
| 09/09/2014 | CA2596755C Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase |
| 09/09/2014 | CA2591766C Tetrahydroquinoline analogues as muscarinic agonists |
| 09/09/2014 | CA2530582C Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 09/09/2014 | CA2516931C Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/09/2014 | CA2436242C Biotin-derivatives and their conjugates with chelating agents |
| 09/04/2014 | WO2014134627A1 Methods for modulating development and function of photoreceptors cells |
| 09/04/2014 | WO2014134621A2 Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis |
| 09/04/2014 | WO2014134620A1 Acne solution |
| 09/04/2014 | WO2014134569A1 Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| 09/04/2014 | WO2014134510A1 Glycopyrrolate salts |
| 09/04/2014 | WO2014134493A1 Broad spectrum antibiotic compounds and use thereof |
| 09/04/2014 | WO2014134477A1 Methods and systems for treating overweight individuals |
| 09/04/2014 | WO2014134466A1 Co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereof |